Truepill
- π¦Became a unicornOct 2021
- πPeak valuation$1.6 Billion β21
- πBecame a UnitardAug 2024
- πΈLast valuation~$528M
The rise & fall
6 moments Β· 2016β2024The key moments, with employee sentiment along the way.
π¬ entries paraphrase anonymous, unverified reviews posted publicly on Glassdoor β; dated facts carry their source.
How it happened
Truepill is a digital pharmacy and healthcare-fulfillment platform powering prescription delivery, telehealth and testing for other brands. A $142M Series D in October 2021 pushed its valuation to $1.6B and unicorn status.
As growth funding dried up, Truepill ran four rounds of layoffs in 2022, refocused on its core pharmacy business, raised a $66M insider round in August 2023, then sold to LetsGetChecked for $525M in August 2024 β about 67% below peak.
Source: Axios; LetsGetChecked acq. $525M (Aug 2024); peak $1.6B (TechCrunch)
Founders
- Umar Afridico-founder & founding CEO (pharmacist)
Current roles as self-reported on LinkedIn, retrieved 2026-08-19. See our methodology.
Disclosed investors (19)
Historical funding participation; lists may be incomplete and do not establish current ownership or investor losses.
* Lead in a funding round Β· Crunchbase β Β· 2026-10-13 Β· Methodology Β· Leaderboard



